Serum adiponectin and vaspin levels in rheumatoid arthritis M Ozgen, SS Koca, N Dagli, M Balin, B Ustundag, A Isik Archives of medical research 41 (6), 457-463, 2010 | 99 | 2010 |
Visfatin levels and intima-media thicknesses in rheumatic diseases M Ozgen, SS Koca, K Aksoy, N Dagli, B Ustundag, A Isik Clinical rheumatology 30, 757-763, 2011 | 68 | 2011 |
Nationwide Experience With Off‐Label Use of Interleukin‐1 Targeting Treatment in Familial Mediterranean Fever Patients S Akar, P Cetin, U Kalyoncu, O Karadag, I Sari, M Cınar, S Yilmaz, ... Arthritis care & research 70 (7), 1090-1094, 2018 | 67 | 2018 |
Serum galectin-3 level in systemic sclerosis SS Koca, F Akbas, M Ozgen, S Yolbas, N Ilhan, B Gundogdu, A Isik Clinical rheumatology 33, 215-220, 2014 | 59 | 2014 |
Prevalence and significance of MEFV gene mutations in a cohort of patients with rheumatoid arthritis SS Koca, EO Etem, B Isik, H Yuce, M Ozgen, MS Dag, A Isik Joint Bone Spine 77 (1), 32-35, 2010 | 56 | 2010 |
The receptor for advanced glycation end product (RAGE) pathway in COVID-19 D Yalcin Kehribar, M Cihangiroglu, E Sehmen, B Avci, A Capraz, ... Biomarkers 26 (2), 114-118, 2021 | 53 | 2021 |
Serum IL-33 level and IL-33 gene polymorphisms in Behçet’s disease SS Koca, M Kara, F Deniz, M Ozgen, CF Demir, N Ilhan, A Isik Rheumatology International 35, 471-477, 2015 | 53 | 2015 |
Ghrelin and obestatin levels in rheumatoid arthritis SS Koca, M Ozgen, S Aydin, S Dag, B Evren, A Isik Inflammation 31, 329-335, 2008 | 52 | 2008 |
Effectiveness of methotrexate in idiopathic granulomatous mastitis treatment DY Kehribar, TI Duran, AK Polat, M Ozgen The American Journal of the Medical Sciences 360 (5), 560-565, 2020 | 42 | 2020 |
The IL-33 gene is related to increased susceptibility to systemic sclerosis SS Koca, Y Pehlivan, M Kara, F Alibaz-Oner, S Oztuzcu, N Yilmaz, ... Rheumatology international 36, 579-584, 2016 | 42 | 2016 |
Epigallocatechin 3‐gallate attenuates arthritis by regulating Nrf2, HO‐1, and cytokine levels in an experimental arthritis model A Karatas, AF Dagli, C Orhan, H Gencoglu, M Ozgen, N Sahin, K Sahin, ... Biotechnology and Applied Biochemistry 67 (3), 317-322, 2020 | 35 | 2020 |
Proteasome inhibition prevents development of experimental dermal fibrosis SS Koca, M Ozgen, F Dagli, M Tuzcu, IH Ozercan, K Sahin, A Isik Inflammation 35, 810-817, 2012 | 34 | 2012 |
Serum salusin-alpha level in rheumatoid arthritis M Ozgen, SS Koca, N Dagli, M Balin, B Ustundag, A Isik Regulatory peptides 167 (1), 125-128, 2011 | 29 | 2011 |
Insulin resistance is related with oxidative stress in systemic lupus erythematosus/Sistemik lupus eritematozda insülin direnci oksidatif stres ile iliskilidir SS Koca, I Karaca, MF Yavuzkir, N Dagli, M Özgen, B Uestuendag, A Isik The Anatolian Journal of Cardiology 9 (1), 23, 2009 | 23 | 2009 |
Association between Thr21Met and Ser89Asn polymorphisms of the urotensin II gene and systemic sclerosis Y Pehlivan, B Gogebakan, S Oztuzcu, M Ozgen, GY Cetin, R Bayraktar, ... The Journal of rheumatology 39 (1), 106-111, 2012 | 20 | 2012 |
Adult‐onset still’s disease and treatment results with tocilizumab S Kır, M Özgen, S Zontul International Journal of Clinical Practice 75 (3), e13936, 2021 | 19 | 2021 |
Investigation of the association between Rho/Rho-kinase gene polymorphisms and systemic sclerosis Y Pehlivan, S Yolbas, GY Cetin, F Alibaz-Oner, Y Cagatay, N Yilmaz, ... Rheumatology international 36, 421-427, 2016 | 16 | 2016 |
Ghrelin prevents the development of dermal fibrosis in bleomycin‐induced scleroderma SS Koca, M Ozgen, M Sarikaya, F Dagli, B Ustundag, A Isik Clinical and experimental dermatology 39 (2), 176-181, 2014 | 16 | 2014 |
Lapatinib ameliorates experimental arthritis in rats M Ozgen, SS Koca, A Karatas, AF Dagli, F Erman, B Gundogdu, K Sahin, ... Inflammation 38, 252-259, 2015 | 14 | 2015 |
Mycophenolate mofetil and daclizumab targeting T lymphocytes in bleomycin‐induced experimental scleroderma M Ozgen, SS Koca, AF Dagli, B Gundogdu, B Ustundag, A Isik Clinical and experimental dermatology 37 (1), 48-54, 2012 | 14 | 2012 |